Los Angeles Dodgers first baseman Freddie Freeman and his wife, Chelsea, recently updated fans on their son Maximus’ condition following his hospitalization.
Chelsea initially shared the news on Instagram, revealing that Max was admitted after experiencing health issues since the All-Star break.
She mentioned that Freddie joined them in the emergency room after a game against the San Francisco Giants.
Diagnosis and Treatment
On Thursday, the Freemans posted a heartfelt update, including a photo of Max, and provided more details about his condition.
They disclosed that Max was diagnosed with Guillain-Barré syndrome, a rare neurological disorder that primarily affects children.
The syndrome, triggered by an infection, leads to symptoms such as weakness and tingling, which can escalate to paralysis.
Fortunately, Max was able to receive timely medical intervention, and his lungs were reinforced.
Freddie, who was in Houston at the time, rushed home immediately after learning about Max’s condition.
After extensive testing, it was confirmed that Max has a severe case of Guillain-Barré syndrome. Though rare, the condition is treatable with blood treatments.
A Challenging Journey Ahead
The Freemans described these past days as the most challenging and frightening of their lives.
They expressed their gratitude for the support and prayers from their followers and shared that Maximus had shown significant improvement recently. “Maximus was taken off his breathing tube and ventilator yesterday, which is a huge win for us,” they wrote.
They remain hopeful and believe in the power of prayer, feeling that they have witnessed a miracle in his recovery.
Dodgers’ Update
While Freddie focuses on his family, the Dodgers continue to hold their top position in the National League West with a 63-46 record. The team will be on the road until August 4, concluding their series with the Oakland Athletics.
TDPel Media
This article was published on TDPel Media. Thanks for reading!Share on Facebook «||» Share on Twitter «||» Share on Reddit «||» Share on LinkedIn